The global Xerostomia (Dry Mouth) Therapeutics market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
GlaxoSmithKline plc
Church & Dwight Co., Inc.
Colgate-Palmolive Company
Hikma Pharmaceuticals PLC
Pendopharm
Sun Pharmaceuticals Industries Ltd.
Lupin Pharmaceuticals, Inc.
Pfizer, Inc.
Parnell Pharmaceuticals, Inc.
Acacia Pharma
OraCoat
By Types:
Salivary Stimulants
Salivary Substitutes
Dentifrices
By Applications:
OTC
Prescription
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2017-2028 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2017-2028. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Xerostomia (Dry Mouth) Therapeutics Market Size Analysis from 2023 to 2028
1.5.1 Global Xerostomia (Dry Mouth) Therapeutics Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Xerostomia (Dry Mouth) Therapeutics Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Xerostomia (Dry Mouth) Therapeutics Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Xerostomia (Dry Mouth) Therapeutics Industry Impact
Chapter 2 Global Xerostomia (Dry Mouth) Therapeutics Competition by Types, Applications, and Top Regions and Countries
2.1 Global Xerostomia (Dry Mouth) Therapeutics (Volume and Value) by Type
2.1.1 Global Xerostomia (Dry Mouth) Therapeutics Consumption and Market Share by Type (2017-2022)
2.1.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue and Market Share by Type (2017-2022)
2.2 Global Xerostomia (Dry Mouth) Therapeutics (Volume and Value) by Application
2.2.1 Global Xerostomia (Dry Mouth) Therapeutics Consumption and Market Share by Application (2017-2022)
2.2.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue and Market Share by Application (2017-2022)
2.3 Global Xerostomia (Dry Mouth) Therapeutics (Volume and Value) by Regions
2.3.1 Global Xerostomia (Dry Mouth) Therapeutics Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Xerostomia (Dry Mouth) Therapeutics Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Xerostomia (Dry Mouth) Therapeutics Consumption by Regions (2017-2022)
4.2 North America Xerostomia (Dry Mouth) Therapeutics Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Xerostomia (Dry Mouth) Therapeutics Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Xerostomia (Dry Mouth) Therapeutics Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Xerostomia (Dry Mouth) Therapeutics Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Xerostomia (Dry Mouth) Therapeutics Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Xerostomia (Dry Mouth) Therapeutics Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Xerostomia (Dry Mouth) Therapeutics Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Xerostomia (Dry Mouth) Therapeutics Sales, Consumption, Export, Import (2017-2022)
4.10 South America Xerostomia (Dry Mouth) Therapeutics Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Xerostomia (Dry Mouth) Therapeutics Market Analysis
5.1 North America Xerostomia (Dry Mouth) Therapeutics Consumption and Value Analysis
5.1.1 North America Xerostomia (Dry Mouth) Therapeutics Market Under COVID-19
5.2 North America Xerostomia (Dry Mouth) Therapeutics Consumption Volume by Types
5.3 North America Xerostomia (Dry Mouth) Therapeutics Consumption Structure by Application
5.4 North America Xerostomia (Dry Mouth) Therapeutics Consumption by Top Countries
5.4.1 United States Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
5.4.2 Canada Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
5.4.3 Mexico Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
Chapter 6 East Asia Xerostomia (Dry Mouth) Therapeutics Market Analysis
6.1 East Asia Xerostomia (Dry Mouth) Therapeutics Consumption and Value Analysis
6.1.1 East Asia Xerostomia (Dry Mouth) Therapeutics Market Under COVID-19
6.2 East Asia Xerostomia (Dry Mouth) Therapeutics Consumption Volume by Types
6.3 East Asia Xerostomia (Dry Mouth) Therapeutics Consumption Structure by Application
6.4 East Asia Xerostomia (Dry Mouth) Therapeutics Consumption by Top Countries
6.4.1 China Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
6.4.2 Japan Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
6.4.3 South Korea Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
Chapter 7 Europe Xerostomia (Dry Mouth) Therapeutics Market Analysis
7.1 Europe Xerostomia (Dry Mouth) Therapeutics Consumption and Value Analysis
7.1.1 Europe Xerostomia (Dry Mouth) Therapeutics Market Under COVID-19
7.2 Europe Xerostomia (Dry Mouth) Therapeutics Consumption Volume by Types
7.3 Europe Xerostomia (Dry Mouth) Therapeutics Consumption Structure by Application
7.4 Europe Xerostomia (Dry Mouth) Therapeutics Consumption by Top Countries
7.4.1 Germany Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
7.4.2 UK Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
7.4.3 France Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
7.4.4 Italy Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
7.4.5 Russia Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
7.4.6 Spain Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
7.4.7 Netherlands Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
7.4.8 Switzerland Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
7.4.9 Poland Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
Chapter 8 South Asia Xerostomia (Dry Mouth) Therapeutics Market Analysis
8.1 South Asia Xerostomia (Dry Mouth) Therapeutics Consumption and Value Analysis
8.1.1 South Asia Xerostomia (Dry Mouth) Therapeutics Market Under COVID-19
8.2 South Asia Xerostomia (Dry Mouth) Therapeutics Consumption Volume by Types
8.3 South Asia Xerostomia (Dry Mouth) Therapeutics Consumption Structure by Application
8.4 South Asia Xerostomia (Dry Mouth) Therapeutics Consumption by Top Countries
8.4.1 India Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
8.4.2 Pakistan Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Xerostomia (Dry Mouth) Therapeutics Market Analysis
9.1 Southeast Asia Xerostomia (Dry Mouth) Therapeutics Consumption and Value Analysis
9.1.1 Southeast Asia Xerostomia (Dry Mouth) Therapeutics Market Under COVID-19
9.2 Southeast Asia Xerostomia (Dry Mouth) Therapeutics Consumption Volume by Types
9.3 Southeast Asia Xerostomia (Dry Mouth) Therapeutics Consumption Structure by Application
9.4 Southeast Asia Xerostomia (Dry Mouth) Therapeutics Consumption by Top Countries
9.4.1 Indonesia Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
9.4.2 Thailand Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
9.4.3 Singapore Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
9.4.4 Malaysia Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
9.4.5 Philippines Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
9.4.6 Vietnam Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
9.4.7 Myanmar Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
Chapter 10 Middle East Xerostomia (Dry Mouth) Therapeutics Market Analysis
10.1 Middle East Xerostomia (Dry Mouth) Therapeutics Consumption and Value Analysis
10.1.1 Middle East Xerostomia (Dry Mouth) Therapeutics Market Under COVID-19
10.2 Middle East Xerostomia (Dry Mouth) Therapeutics Consumption Volume by Types
10.3 Middle East Xerostomia (Dry Mouth) Therapeutics Consumption Structure by Application
10.4 Middle East Xerostomia (Dry Mouth) Therapeutics Consumption by Top Countries
10.4.1 Turkey Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
10.4.3 Iran Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
10.4.5 Israel Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
10.4.6 Iraq Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
10.4.7 Qatar Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
10.4.8 Kuwait Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
10.4.9 Oman Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
Chapter 11 Africa Xerostomia (Dry Mouth) Therapeutics Market Analysis
11.1 Africa Xerostomia (Dry Mouth) Therapeutics Consumption and Value Analysis
11.1.1 Africa Xerostomia (Dry Mouth) Therapeutics Market Under COVID-19
11.2 Africa Xerostomia (Dry Mouth) Therapeutics Consumption Volume by Types
11.3 Africa Xerostomia (Dry Mouth) Therapeutics Consumption Structure by Application
11.4 Africa Xerostomia (Dry Mouth) Therapeutics Consumption by Top Countries
11.4.1 Nigeria Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
11.4.2 South Africa Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
11.4.3 Egypt Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
11.4.4 Algeria Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
11.4.5 Morocco Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
Chapter 12 Oceania Xerostomia (Dry Mouth) Therapeutics Market Analysis
12.1 Oceania Xerostomia (Dry Mouth) Therapeutics Consumption and Value Analysis
12.2 Oceania Xerostomia (Dry Mouth) Therapeutics Consumption Volume by Types
12.3 Oceania Xerostomia (Dry Mouth) Therapeutics Consumption Structure by Application
12.4 Oceania Xerostomia (Dry Mouth) Therapeutics Consumption by Top Countries
12.4.1 Australia Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
12.4.2 New Zealand Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
Chapter 13 South America Xerostomia (Dry Mouth) Therapeutics Market Analysis
13.1 South America Xerostomia (Dry Mouth) Therapeutics Consumption and Value Analysis
13.1.1 South America Xerostomia (Dry Mouth) Therapeutics Market Under COVID-19
13.2 South America Xerostomia (Dry Mouth) Therapeutics Consumption Volume by Types
13.3 South America Xerostomia (Dry Mouth) Therapeutics Consumption Structure by Application
13.4 South America Xerostomia (Dry Mouth) Therapeutics Consumption Volume by Major Countries
13.4.1 Brazil Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
13.4.2 Argentina Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
13.4.3 Columbia Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
13.4.4 Chile Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
13.4.5 Venezuela Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
13.4.6 Peru Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
13.4.8 Ecuador Xerostomia (Dry Mouth) Therapeutics Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Xerostomia (Dry Mouth) Therapeutics Business
14.1 GlaxoSmithKline plc
14.1.1 GlaxoSmithKline plc Company Profile
14.1.2 GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Product Specification
14.1.3 GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Church & Dwight Co., Inc.
14.2.1 Church & Dwight Co., Inc. Company Profile
14.2.2 Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Product Specification
14.2.3 Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Colgate-Palmolive Company
14.3.1 Colgate-Palmolive Company Company Profile
14.3.2 Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Product Specification
14.3.3 Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Hikma Pharmaceuticals PLC
14.4.1 Hikma Pharmaceuticals PLC Company Profile
14.4.2 Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Product Specification
14.4.3 Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Pendopharm
14.5.1 Pendopharm Company Profile
14.5.2 Pendopharm Xerostomia (Dry Mouth) Therapeutics Product Specification
14.5.3 Pendopharm Xerostomia (Dry Mouth) Therapeutics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Sun Pharmaceuticals Industries Ltd.
14.6.1 Sun Pharmaceuticals Industries Ltd. Company Profile
14.6.2 Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Product Specification
14.6.3 Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Lupin Pharmaceuticals, Inc.
14.7.1 Lupin Pharmaceuticals, Inc. Company Profile
14.7.2 Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Product Specification
14.7.3 Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Pfizer, Inc.
14.8.1 Pfizer, Inc. Company Profile
14.8.2 Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Product Specification
14.8.3 Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Parnell Pharmaceuticals, Inc.
14.9.1 Parnell Pharmaceuticals, Inc. Company Profile
14.9.2 Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Product Specification
14.9.3 Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Acacia Pharma
14.10.1 Acacia Pharma Company Profile
14.10.2 Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Product Specification
14.10.3 Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 OraCoat
14.11.1 OraCoat Company Profile
14.11.2 OraCoat Xerostomia (Dry Mouth) Therapeutics Product Specification
14.11.3 OraCoat Xerostomia (Dry Mouth) Therapeutics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Xerostomia (Dry Mouth) Therapeutics Market Forecast (2023-2028)
15.1 Global Xerostomia (Dry Mouth) Therapeutics Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Xerostomia (Dry Mouth) Therapeutics Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Xerostomia (Dry Mouth) Therapeutics Value and Growth Rate Forecast (2023-2028)
15.2 Global Xerostomia (Dry Mouth) Therapeutics Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Xerostomia (Dry Mouth) Therapeutics Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Xerostomia (Dry Mouth) Therapeutics Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Xerostomia (Dry Mouth) Therapeutics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Xerostomia (Dry Mouth) Therapeutics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Xerostomia (Dry Mouth) Therapeutics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Xerostomia (Dry Mouth) Therapeutics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Xerostomia (Dry Mouth) Therapeutics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Xerostomia (Dry Mouth) Therapeutics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Xerostomia (Dry Mouth) Therapeutics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Xerostomia (Dry Mouth) Therapeutics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Xerostomia (Dry Mouth) Therapeutics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Xerostomia (Dry Mouth) Therapeutics Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Xerostomia (Dry Mouth) Therapeutics Consumption Forecast by Type (2023-2028)
15.3.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue Forecast by Type (2023-2028)
15.3.3 Global Xerostomia (Dry Mouth) Therapeutics Price Forecast by Type (2023-2028)
15.4 Global Xerostomia (Dry Mouth) Therapeutics Consumption Volume Forecast by Application (2023-2028)
15.5 Xerostomia (Dry Mouth) Therapeutics Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
| Price : US$ 3500 |
Date : Nov 2024 |
| Category : Services |
Pages : 139 |
Request Sample 
Request Discount 
Inquire Before Buy
